Evaluation of MAF-1217 in Patients With DED
Condition(s):Evaporative Dry Eye DiseaseLast Updated:July 15, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Evaporative Dry Eye DiseaseLast Updated:July 15, 2019Completed
Condition(s):Ocular Complications; Eye ProtocolLast Updated:February 5, 2024Recruiting
Condition(s):Primary Sjogren; Secondary Sjogren; XerostomiaLast Updated:May 22, 2008Completed
Condition(s):Meibomian Gland DysfunctionLast Updated:February 20, 2024Recruiting
Condition(s):Mite-BorneLast Updated:June 30, 2020Unknown status
Condition(s):Dry Eye Syndromes; Dry Eye; Ocular Surface DiseaseLast Updated:December 7, 2023Completed
Condition(s):Cataract; Dry EyeLast Updated:April 29, 2020Completed
Condition(s):Eye Diseases; Ocular Surface Disease; Dry EyeLast Updated:July 14, 2021Completed
Condition(s):Corneal Disease; Neuropathy; Dry Eye Disease; Neurotrophic KeratitisLast Updated:January 22, 2024Enrolling by invitation
Condition(s):GlaucomaLast Updated:March 16, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.